Learn More
Medchemexpress LLC 4-((Z)-4-oxo-2-thioxo-3-(3-(trifluoromethyl)benzyl)thiazolidin-5-ylidene)methyl benzoic acid | 1073612-91-5 | MFCD31619349 | 99.6% | 423.43 g/mol | C19H12F3NO3S2 | 50 MG

Supplier: Medchemexpress LLC HY10366650MG
CY-09 is a selective, direct small-molecule inhibitor of the NLRP3 inflammasome that binds the ATP-binding motif of the NLRP3 NACHT domain, inhibiting NLRP3 ATPase activity and suppressing inflammasome assembly and activation. It is supplied as a solid for research use in studies of inflammatory signaling and innate immunity.
- Selective NLRP3 inhibitor that binds the NLRP3 ATP-binding motif.
- Inhibits NLRP3 ATPase activity to block inflammasome assembly.
- Applicable to research on inflammation, innate immunity, and disease models.
- Solid, light yellow to yellow appearance; high purity suitable for biochemical assays.
- Recommended storage: powder at -20°C for long term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.